Method of nucleotide detection
US-9303290-B2 · Apr 5, 2016 · US
US9970055B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9970055-B2 |
| Application number | US-201615050337-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 22, 2016 |
| Priority date | Dec 13, 2004 |
| Publication date | May 15, 2018 |
| Grant date | May 15, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to an additive which can be added to buffers used in nucleotide detection processes and improved methods of nucleic acid sequencing using this additive. In particular the invention relates to use of the additive to improve the efficiency of fluorescence-based multiple cycle nucleic acid sequencing reactions.
Opening claim text (preview).
The invention claimed is: 1. A kit for sequencing a nucleic acid template, the kit comprising: a plurality of fluorescently labelled nucleotides; an enzyme capable of catalyzing incorporation of the fluorescently labelled nucleotides into a nucleic acid strand complementary to the nucleic acid template to be sequenced; and a buffer comprising ascorbic acid or a salt thereof, or a supply of ascorbic acid or a salt thereof suitable for preparing the buffer. 2. The kit of claim 1 , wherein the salt of ascorbic acid is sodium ascorbate. 3. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of at least 10 mM. 4. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of at least 20 mM. 5. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of up to 50 mM. 6. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration of up to 100 mM. 7. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration ranging from 10 to 100 mM. 8. The kit of claim 1 , wherein the ascorbic acid or salt thereof is present in the buffer at a concentration ranging from 20 to 50 mM. 9. The kit of claim 1 , wherein the buffer has a pH of about 5 to about 9. 10. The kit of claim 1 , wherein the buffer has a pH of about 5.5 to about 8.6. 11. The kit of claim 1 , wherein the buffer has a pH of about 7. 12. The kit of claim 1 , wherein the fluorescently labelled nucleotides are dNTPs. 13. The kit of claim 1 , further comprising an enzyme cofactor required for incorporation of the fluorescently labelled nucleotides into a growing nucleic acid strand. 14. The kit of claim 1 , wherein the buffer further comprises an enzyme, an enzyme cofactor, an oligonucleotide primer, dNTPs, or a combination thereof. 15. The kit of claim 1 , wherein the buffer further comprises an additional antioxidant. 16. The kit of claim 1 , wherein the fluorescent label is attached to the nucleotides by a linker comprising a disulfide. 17. The kit of claim 1 , wherein the fluorescent label is attached to the nucleotides by a linker comprising an azide. 18. The kit of claim 17 , wherein the azide containing linker is cleavable by a phosphine.
Methods for sequencing · CPC title
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
Chemical cleaving agents · CPC title
Specific component of sample, medium or buffer · CPC title
fluorescence · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.